MX2017015545A - Sistema de administracion oral para agentes bioactivos. - Google Patents

Sistema de administracion oral para agentes bioactivos.

Info

Publication number
MX2017015545A
MX2017015545A MX2017015545A MX2017015545A MX2017015545A MX 2017015545 A MX2017015545 A MX 2017015545A MX 2017015545 A MX2017015545 A MX 2017015545A MX 2017015545 A MX2017015545 A MX 2017015545A MX 2017015545 A MX2017015545 A MX 2017015545A
Authority
MX
Mexico
Prior art keywords
delivery system
bioactive agents
oral delivery
oral administration
administration system
Prior art date
Application number
MX2017015545A
Other languages
English (en)
Other versions
MX385351B (es
Inventor
Wadsworth Simon
Klaric Goran
Nalin Jayasingh Suwan
Original Assignee
Ewos Innovation As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB1509608.4A external-priority patent/GB2539006A/en
Priority claimed from NO20150715A external-priority patent/NO344096B1/en
Application filed by Ewos Innovation As filed Critical Ewos Innovation As
Publication of MX2017015545A publication Critical patent/MX2017015545A/es
Publication of MX385351B publication Critical patent/MX385351B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)

Abstract

La presente invención hace referencia a un alimento funcional y un sistema de administración oral para administrar macromoléculas bioactivas. El sistema de administración oral comprende alginato de etilendiamonio que es un vehículo para administrar fármacos macromoleculares. El sistema de administración oral de acuerdo con la presente invención es particularmente adecuado para usarse en combinación con alimentos funcionales en peces.
MX2017015545A 2015-06-03 2016-06-02 Sistema de administracion oral para agentes bioactivos. MX385351B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1509608.4A GB2539006A (en) 2015-06-03 2015-06-03 Functional feed
NO20150715A NO344096B1 (en) 2015-06-03 2015-06-03 Oral delivery system for bioactive active agents
PCT/NO2016/050113 WO2016195509A1 (en) 2015-06-03 2016-06-02 Oral delivery system for bioactive agents

Publications (2)

Publication Number Publication Date
MX2017015545A true MX2017015545A (es) 2018-11-09
MX385351B MX385351B (es) 2025-03-18

Family

ID=56360457

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017015545A MX385351B (es) 2015-06-03 2016-06-02 Sistema de administracion oral para agentes bioactivos.

Country Status (9)

Country Link
US (2) US20180147147A1 (es)
EP (2) EP3881835B1 (es)
CN (1) CN108076627B (es)
BR (1) BR112017026013B1 (es)
CA (1) CA2987932C (es)
CL (1) CL2017003077A1 (es)
EC (1) ECSP18000069A (es)
MX (1) MX385351B (es)
WO (1) WO2016195509A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102018126394B4 (de) * 2018-10-23 2020-12-24 Universität Rostock Probiotika enthaltendes Depotsystem für dentale Anwendungen
KR102866023B1 (ko) * 2022-06-13 2025-09-29 부산대학교 산학협력단 산성 환경에서 프로바이오틱스를 보호하는 하이드록시아파타이트-하이드로겔 복합체 및 이를 포함하는 프로바이오틱스 전달용 조성물
CN120599695B (zh) * 2025-05-27 2025-12-26 安徽农业大学 一种鱼类摄食行为识别方法及系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935250A (en) * 1984-05-01 1990-06-19 Inverness Management Corporation Coated fish feed pellets
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
US5658592A (en) * 1994-05-13 1997-08-19 Kuraray Co., Ltd. Medical crosslinked polymer gel of carboxylic polysaccharide and diaminoalkane
SE9401738D0 (sv) * 1994-05-19 1994-05-19 Ewos Ab Bioactive feed
FR2799196B1 (fr) * 1999-10-04 2002-02-08 Sod Conseils Rech Applic Copolymeres reticules a base de copolymeres polycarboxyliques non reticules
JP4565691B2 (ja) * 2000-02-28 2010-10-20 株式会社Phg ヘパリン結合性成長因子用徐放基材、およびヘパリン結合性成長因子徐放剤
SE0103613D0 (sv) * 2001-10-30 2001-10-30 Astrazeneca Ab Novel formulation
NO320671B1 (no) * 2001-11-30 2006-01-16 Fmc Biopolymer As Fremgangsmate for a stimulere vektokning i fisk.
NZ539900A (en) * 2002-11-07 2008-03-28 Advanced Bionutrition Corp Nutraceuticals and method of feeding aquatic animals
CN1268346C (zh) * 2003-11-19 2006-08-09 上海中科伍佰豪生物工程有限公司 生物多糖微胶囊及其制备方法和用途
WO2005115341A2 (en) * 2004-05-27 2005-12-08 Advanced Bionutrition Corporation Microparticles for oral delivery
ITMI20052461A1 (it) * 2005-12-22 2007-06-23 Univ Degli Studi Milano Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
CN101549158A (zh) 2009-05-08 2009-10-07 南开大学 一种海藻酸钠肝靶向纳米给药系统及其制备方法
JP2013534134A (ja) 2010-08-03 2013-09-02 ジョーロックス ピーティワイ リミテッド 補助食品を食物製品に含有させるための真空注入
UA103834C2 (ru) * 2012-06-15 2013-11-25 Павел Петрович Пивоваров Капсулированный белоксодержащий продукт и способ его получения
CN103627010A (zh) * 2013-11-18 2014-03-12 戴建英 一种海藻酸酰胺类医用敷料的制备方法

Also Published As

Publication number Publication date
CA2987932C (en) 2024-01-16
EP3881835A1 (en) 2021-09-22
BR112017026013B1 (pt) 2023-12-05
BR112017026013A2 (pt) 2018-08-14
US20180147147A1 (en) 2018-05-31
CA2987932A1 (en) 2016-12-08
CN108076627A (zh) 2018-05-25
MX385351B (es) 2025-03-18
US11844863B2 (en) 2023-12-19
US20220409541A1 (en) 2022-12-29
WO2016195509A1 (en) 2016-12-08
ECSP18000069A (es) 2018-10-31
CN108076627B (zh) 2021-05-25
EP3881835B1 (en) 2026-04-01
EP3302445A1 (en) 2018-04-11
CL2017003077A1 (es) 2019-07-19

Similar Documents

Publication Publication Date Title
BR112017005693A2 (pt) método para tratar e/ou prevenir uma doença hepática, e, composição farmacêutica.
MX2022004374A (es) Composiciones de agonista de tlr9 e inhibidores de punto de control para usarse en la respuesta inmune contra el cancer.
CL2015003545A1 (es) Una capsula para preparar composiciones comestibles
MX2018001723A (es) Conjugados farmaco-multiligando y usos de los mismos.
BR112018010671A8 (pt) dispositivos e métodos de distribuição de fármaco com mudança de forma
MX2017005236A (es) Profarmacos de carbidopa y l-dopa y metodos de uso.
DOP2016000150A (es) Nuevas indazolcarboxamidas, procedimientos para su preparación, preparaciones farmacéuticas que las contienen, así como su uso para la preparación de medicamentos
MX2018009230A (es) Formulaciones nutritivas que comprenden un aislado de proteina de guisante.
BR112018077021A2 (pt) terapias de combinação
BR112015021002B8 (pt) Forma de dosagem sólida farmacêutica compreendendo um ingrediente farmacêutico ativo
BR112016016290A2 (pt) Composições farmacêuticas de insulina de ação rápida, conjunto de infusão, sistema de conjunto de infusão e usos de análogos monoméricos ou diméricos de insulina
CL2017000664A1 (es) Micropartículas inyectables para la liberación hiper-localizada de agentes terapéuticos
CO2018003424A2 (es) Composición farmacéutica y formulación de inyección subcutánea que comprende micelas y curcuminoides para reducir la grasa localizada y método para preparar la misma”
EP3445416A4 (en) ENTERALES ACTIVE COMPOSITION SYSTEM
BR112017015159A2 (pt) preparação e uso de produtos plaquetários
MX386374B (es) Composiciones farmacéuticas y alimenticias para inducir la saciedad y prolongar la saciedad en sujetos que lo necesiten.
MX2017015545A (es) Sistema de administracion oral para agentes bioactivos.
BR112017026834A2 (pt) composição compreendendo vitaminas b e vitaminas c e seu uso
PE20151556A1 (es) Metodo para la determinacion de la intensidad de la actividad de modificacion de los medicamentos bipaticos
EP3337389A4 (en) INTEGRATED FASTENING DEVICE COMPRISING AN EMISSION AND RECOVERY SOURCE FOR TARGET LOCATION AND LATCHING IN RELATION TO THE FASTENING POINT TO FACILITATE INTERVENTION ON THE TARGET
BR112017024732A2 (pt) combinação farmacêutica de everolimus com dactolisibe
CL2015001104A1 (es) Composición de la alimentación para peces
MX2016014701A (es) (r)-pirlindol y sus sales farmaceuticamente aceptables para uso en medicina.
BR112014017160A2 (pt) sistema de administração de fragrância duradoura
EA201691964A1 (ru) Конъюгаты для доставки лекарственного средства для лечения устойчивой формы рака и для применения в комбинированной терапии